Shardul Amarchand Mangaldas & Co advised Book Running Lead Managers on ₹ 1,200 crores QIP of Max Healthcare Institute
Shardul Amarchand Mangaldas & Co advised Book Running Lead Managers on ₹ 1,200 crores QIP of Max Healthcare Institute Shardul Amarchand Mangaldas & Co advised Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Credit Suisse Securities (India) Private Limited, HSBC Securities and Capital Markets (India) Private Limited (Book Running...
ToRead the Full Story, Subscribe to
Access the exclusive LEGAL ERAStories,Editorial and Expert Opinion
Shardul Amarchand Mangaldas & Co advised Book Running Lead Managers on ₹ 1,200 crores QIP of Max Healthcare Institute
Shardul Amarchand Mangaldas & Co advised Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Credit Suisse Securities (India) Private Limited, HSBC Securities and Capital Markets (India) Private Limited (Book Running Lead Managers) on the ₹ 1,200 crores qualified institutional placement (QIP) of Max Healthcare Institute Limited. The date of closing was 10 March 2021.
Max Healthcare Institute Limited is India's second largest private healthcare network by revenue and has a network of 16 Network Healthcare Facilities.
This will be the third healthcare transaction in 2021 for the capital markets team following the Apollo Hospitals QIP (in January 2021) and the initial public offer of Krishna Institute of Medical Sciences Limited (DRHP filed in February 2021).
The transaction team was led by Prashant Gupta, National Practice Head and Monal Mukherjee, Partner; assisted by Anjali Verghese, Senior Associate; Maharghya Biswas, Associate; Sanjana Chowdhry, Associate; and Rudresh Mandal, Associate.
AZB & Partners advised Max Healthcare Institute Limited. Linklaters Singapore Pte. Ltd. advised the Book Running Lead Managers as to United States law.
